07/16/2025 3:11 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2025 3:30 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/19/2025 6:32 AM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2025 6:00 AM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2025 3:15 PM | Sarepta Therapeutics (Filer)
| Form ARS | |
03/13/2025 7:00 PM | Nicaise Claude (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 4:33 PM | Nicaise Claude (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025 7:00 PM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Nicaise Claude (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SRPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/11/2025 7:00 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Rothfuss Cristin (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:00 PM | Connelly Deirdre P (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 7:00 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 7:00 PM | Rothfuss Cristin (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 7:00 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 7:00 PM | Rothfuss Cristin (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:00 PM | Rothfuss Cristin (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 7:00 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2025 3:05 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 12:32 PM | Capital International Investors (Filed by) Sarepta Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 7:38 AM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2025 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 7:00 PM | Murray Dallan (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad) Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. |
02/13/2025 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 7:30 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 11:25 AM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/30/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 7:00 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 4:06 PM | Sarepta Therapeutics (Subject) Wigzell Hans Lennart Rudolf (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 3:18 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024 7:15 PM | Rothfuss Cristin (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 7:00 PM | Rothfuss Cristin (Reporting) Sarepta Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/26/2024 6:17 AM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 8:40 AM | JANUS HENDERSON GROUP PLC (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024 9:27 AM | Capital International Investors (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
09/16/2024 7:00 PM | Connelly Deirdre P (Reporting) Sarepta Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/16/2024 7:05 PM | Connelly Deirdre P (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 7:51 AM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 7:00 PM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 4:03 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 7:00 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 3:50 PM | Sarepta Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2024 3:01 PM | Sarepta Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |